Tesamorilin
Experience a new level of convenience and affordability with Saveco’s Tesamorilin.
Tesamorelin is a synthetic analogue of the growth hormone-releasing hormone (GHRH) that includes an extra trans-3-hexanoic acid group. Developed by Theratechnologies in Canada, tesamorelin was approved by the FDA in 2010 as a treatment for HIV-associated lipodystrophy. This condition results in abnormal accumulation of fat in the abdomen and other areas of the body, often as a result of antiretroviral therapy.
Before the approval of tesamorelin, patients had few effective treatment options beyond diet and exercise, and surgical intervention was often unsuccessful. Tesamorelin has been found to reduce adiposity by almost 20%, making it significantly more effective than other available treatments.
Currently, tesamorelin is being investigated for its potential to reduce cardiovascular disease in individuals with HIV, promote peripheral nerve regeneration, and slow the progression of mild cognitive impairment (MCI), a precursor to dementia. Ongoing clinical trials are exploring these potential therapeutic applications. As tesamorelin is already approved by the FDA for use in humans, it is a promising subject for continued research.
Benefits of Tesamorilin
Tesamorelin is best known for its ability to significantly reduce abdominal visceral fat, making it a leading compound in obesity, lipodystrophy, and metabolic health research.
By naturally increasing GH, Tesamorelin helps support muscle development and prevent muscle wasting, making it ideal for body composition and performance-based studies.
Studies have shown Tesamorelin can enhance lipid profiles, reduce triglycerides, and improve glucose metabolism, making it a key compound in type 2 diabetes and metabolic syndrome research.
Through elevated GH levels, Tesamorelin contributes to deeper sleep, better recovery, and more sustained energy, all of which are crucial in performance and wellness research.
With high purity (98.4%) and accurate daily administration, Tesamorelin offers controlled, consistent results in both short- and long-term studies.
Research-Grade Tesamorilin – Full Description
- Cost $99
- Unit Size 2 mg/vial
- Unit Quantity 1 vial
- Purity (HPLC) 98.4%
- Sequence Unk-Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser-Asn-Gln-Glu-Arg-Gly-Ala-Arg-Ala-Arg-Leu-NH2.CH3CO2H
- Molecular Formula C221H366N72O67S
- Molecular Weight 5135.86
- CAS 901758-09-6
- Appearance lyophilized White Powder
- Source Chemical Synthesis
- Storage Store in a cool, dry place with minimal air exposure.
Terms The products we offer are intended for laboratory research use only. Please familiarize yourself with our terms of service prior to ordering.
Mix each vial with: Bacteriostatic water. 1-2ml depending on desired dissolution.
Administration: 1-2 mg/ daily